Variability of the paracrine‐induced osteoclastogenesis by human breast cancer cell lines
Open Access
- 17 November 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 113 (3) , 1069-1079
Abstract
Breast cancer frequently metastasizes to the bone, often leading to the formation of osteolytic lesions. This work compares the paracrine-induced osteoclastogenesis mediated by four human breast cancer cell lines, the estrogen-receptor positive T47D and MCF-7 and the estrogen-negative SK-BR-3 and Hs-578T cell lines. Human osteoclast precursor cells were cultured in the presence of conditioned media from the breast cancer cell lines (10% and 20%), collected at different culture periods (48 h, 7 days, and 14 days). Cultures performed in the absence or the presence of M-CSF and RANKL served as negative and positive control, respectively. Results showed that the cell lines differentially expressed several osteoclastogenic genes. All cell lines exhibited a significant osteoclastogenic potential, evidenced by a high TRAP activity and number of osteoclastic cells, expression of several osteoclast-related genes, and, particularly, a high calcium phosphate resorption activity. Differences among the osteoclastogenic potential of the cell lines were noted. T47D and MCF-7 cell lines displayed the highest and the lowest osteoclastogenic response, respectively. Despite the variability observed, MEK and NF-κB signaling pathways, and, at a lesser extent, PGE2 production, seemed to have a central role on the observed osteoclastogenic response. In conclusion, the tested breast cancer cell lines exhibited a high osteoclastogenic potential, although with some variability on the cell response profile, a factor to be considered in the development of new therapeutic approaches for breast cancer-induced bone metastasis. J. Cell. Biochem. 113: 1069–1079, 2012.Keywords
This publication has 53 references indexed in Scilit:
- Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblastsCell Proliferation, 2011
- The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expressionMolecular Cancer Therapeutics, 2009
- Pathway crosstalk between Ras/Raf and PI3K in promotion of M‐CSF‐induced MEK/ERK‐mediated osteoclast survivalJournal of Cellular Biochemistry, 2008
- Phosphatidylinositol 3-kinase, MEK-1 and p38 mediate leptin/interferon-gamma synergistic NOS type II induction in chondrocytesLife Sciences, 2007
- Osteoclast differentiation and gene regulationFrontiers in Bioscience-Landmark, 2007
- Molecular analysis of RANKL‐independent cell fusion of osteoclast‐like cells induced by TNF‐α, lipopolysaccharide, or peptidoglycanJournal of Cellular Biochemistry, 2006
- Osteoclast differentiation and activationNature, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Breast Cancer Cell Line MDA-231 Stimulates Osteoclastogenesis and Bone Resorption in Human OsteoclastsBiochemical and Biophysical Research Communications, 2000
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976